Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]

Saved in:
Bibliographic Details
Published in:OncoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552795020328960
collection WordPress RSS
FRELIP Feed Integration
container_title OncoTargets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61306
institution FRELIP
journal_source_facet OncoTargets and Therapy
last_indexed 2026-06-20T21:26:42.861Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_alt Nanopartículas híbridas de lípido-polímero cargadas con doxorrubicina y edelfosina para efecto anticancerígeno sinérgico contra osteosarcoma resistente a fármacos [Retractación]
Nanoparticules hybrides lipide-polymère chargées de doxorubicine et d'edelfosine pour un effet anticancéreux synergique contre l'ostéosarcome résistant aux médicaments [Rétractation]
Nanopartículas híbridas de lipídio-polímero carregadas com combinação de Doxorrubicina e Edelfosina para efeito anticancerígeno sinérgico contra osteossarcoma resistente a drogas [Retratação]
title_auth Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_es_txt Nanopartículas híbridas de lípido-polímero cargadas con doxorrubicina y edelfosina para efecto anticancerígeno sinérgico contra osteosarcoma resistente a fármacos [Retractación]
title_fr_txt Nanoparticules hybrides lipide-polymère chargées de doxorubicine et d'edelfosine pour un effet anticancéreux synergique contre l'ostéosarcome résistant aux médicaments [Rétractation]
title_full Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_fullStr Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_full_unstemmed Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_pt_txt Nanopartículas híbridas de lipídio-polímero carregadas com combinação de Doxorrubicina e Edelfosina para efeito anticancerígeno sinérgico contra osteossarcoma resistente a drogas [Retratação]
title_short Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma [Retraction]
title_sort doxorubicin and edelfosine combo-loaded lipid–polymer hybrid nanoparticles for synergistic anticancer effect against drug-resistant osteosarcoma [retraction]
topic Oncology
General
Oncology
url https://www.dovepress.com/retraction-doxorubicin-and-edelfosine-combo-loaded-lipidndashpolymer-h-peer-reviewed-fulltext-article-OTT